Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy
Clinical trial NCT03457142 · TERMINATED
Trial details
- NCT number
- NCT03457142
- Sponsor
- Roswell Park Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-11
- Primary completion
- 2022-11-21
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.